Valuation: Medpace Holdings, Inc.

Market Cap 17.37B 15.48B 14.33B 12.97B 24.44B 1,639B 24.73B 172B 67.43B 862B 65.17B 63.81B 2,746B P/E 2026 *
35.4x
P/E 2027 * 32.5x
Enterprise Value 16.59B 14.79B 13.69B 12.39B 23.34B 1,566B 23.62B 164B 64.4B 823B 62.24B 60.95B 2,623B EV / Sales 2026 *
5.82x
EV / Sales 2027 * 5.32x
Free-Float
81.03%
Yield 2026 *
-
Yield 2027 * -
1 day+4.80%
1 week+5.96%
Current month+4.68%
1 month+4.67%
3 months+22.89%
6 months+26.89%
Current year+16.33%
1 week 610.05
Extreme 610.05
666.65
1 month 587.38
Extreme 587.385
666.65
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 30/06/1992
Director of Finance/CFO 51 31/07/2021
Chief Tech/Sci/R&D Officer 65 31/08/2017
Director TitleAgeSince
Chairman 69 30/06/1992
Director/Board Member 55 30/06/2016
Director/Board Member 72 30/06/2016
Date Insider Type Main position Quantity % Market Cap. Importance
12/10/26 Exercice

Chief Operating Officer

6,000 0.0215%
07/10/26 Exercice

Chief Operating Officer

4,000 0.0143%
30/09/26 Sell

Chief Executive Officer

-21,966 0.0787%
Change 5-day change 1-year change 3-year change Capi.($)
+4.78%+5.96%+19.74%+187.17% 17.37B
-0.21%-6.36%+49.00%+74.13% 66.34B
-0.22%+6.53%+11.68%+90.35% 52.92B
+0.82%+5.41%+8.05%+74.45% 54.82B
+2.70%+4.96%+25.76%+49.69% 44.09B
+0.97%+10.52%+23.03%+130.22% 43.72B
-0.46%+1.21%+266.16%+967.07% 42.13B
+0.10%+9.96%+17.15%+59.33% 33.96B
-1.30%-3.61%+37.37%+7.16% 26.17B
+0.69%+5.60%+36.60%+26.39% 23.37B
Average +0.76%+4.51%+49.46%+166.60% 40.49B
Weighted average by Cap. +0.53%+4.56%+50.45%+169.13%

Financials

2026 *2027 *
Net sales 2.85B 2.54B 2.35B 2.13B 4.01B 269B 4.06B 28.21B 11.07B 141B 10.7B 10.48B 451B 3.03B 2.7B 2.5B 2.26B 4.27B 286B 4.32B 30B 11.77B 150B 11.38B 11.14B 479B
Net income 503M 448M 415M 375M 707M 47.43B 715M 4.97B 1.95B 24.93B 1.89B 1.85B 79.45B 546M 487M 451M 408M 768M 51.56B 778M 5.4B 2.12B 27.1B 2.05B 2.01B 86.35B
Net Debt -780M -695M -644M -583M -1.1B -73.62B -1.11B -7.72B -3.03B -38.7B -2.93B -2.87B -123B -1.24B -1.11B -1.03B -929M -1.75B -117B -1.77B -12.3B -4.83B -61.7B -4.67B -4.57B -197B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
21/10/26 US$654.57 +5.16% 580,081
20/10/26 US$622.43 +0.45% 403,823
19/10/26 US$619.66 +0.19% 247,111
16/10/26 US$618.47 -1.61% 325,148
15/10/26 US$628.60 +1.94% 391,773
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
622.43USD
Average target price
595.92USD
Spread / Average Target
-4.26%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medpace Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MEDP Stock